---
title: "Artivion amends agreements with Endospan"
date: "2024-07-08T09:52:22.000Z"
publishedDate: "8 juillet 2024"
summary: "Artivion recently announced it has amended its credit facility and option purchase agreements with Endospan, developer of the Nexus stent graft system. In 2019, Artivion provided a credit facility to Endospan and entered into an option agreement to purchase Endospan upon US Food and Drug Administration (FDA) approval of Nexus."
importance: ""
sourceUrl: "https://vascularnews.com/artivion-amends-agreements-with-endospan/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2024-07-08-artivion-amends-agreements-with-endospan"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2022/01/Artivion-logo.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/artivion-amends-agreements-with-endospan/"
---

![Artivion amends agreements with Endospan](https://vascularnews.com/wp-content/uploads/sites/7/2022/01/Artivion-logo.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/artivion-amends-agreements-with-endospan/*

## L’essentiel

Artivion recently announced it has amended its credit facility and option purchase agreements with Endospan, developer of the Nexus stent graft system. In 2019, Artivion provided a credit facility to Endospan and entered into an option agreement to purchase Endospan upon US Food and Drug Administration (FDA) approval of Nexus.

## Lien source

https://vascularnews.com/artivion-amends-agreements-with-endospan/
